These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1359366)

  • 1. The effect of amperozide, a new antipsychotic drug, on plasma corticosterone concentration in the rat.
    Albinsson A; Andersson G
    Life Sci; 1992; 51(19):1535-44. PubMed ID: 1359366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
    Meltzer HY; Zhang Y; Stockmeier CA
    Eur J Pharmacol; 1992 May; 216(1):67-71. PubMed ID: 1388121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and biochemical effects of amperozide and serotonin agents on nigrostriatal and mesolimbic dopamine systems.
    Chang PY; Chuang CH; Chen JC; Tung CS
    Chin J Physiol; 2008 Apr; 51(2):106-15. PubMed ID: 18666714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective down-regulation of the agonist-dependent high affinity state of rat cortical 5-HT2 receptors following chronic treatment with amperozide.
    Svartengren JO
    J Recept Res; 1993; 13(1-4):379-92. PubMed ID: 8450497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Kuroki T; Dai J; Meltzer HY
    Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P; Nomikos GG; Svensson TH
    Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The limbic functional selectivity of amperozide is not mediated by dopamine D2 receptors as assessed by in vitro and in vivo binding.
    Svartengren J; Celander M
    Eur J Pharmacol; 1994 Mar; 254(1-2):73-81. PubMed ID: 7911431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor binding properties of amperozide.
    Svartengren J; Simonsson P
    Pharmacol Toxicol; 1990; 66 Suppl 1():8-11. PubMed ID: 2154737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats.
    Uvnäs-Moberg K; Alster P; Svensson TH
    Psychopharmacology (Berl); 1992; 109(4):473-6. PubMed ID: 1365865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats.
    McMillen BA; Jones EA; Hill LJ; Williams HL; Björk A; Myers RD
    Pharmacol Biochem Behav; 1993 Sep; 46(1):125-9. PubMed ID: 8255902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization.
    Waters N; Pettersson G; Carlsson A; Svensson K
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):161-9. PubMed ID: 2572972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of amperozide and tiospirone, atypical antipsychotic 5-HT2 drugs, on food-reinforced behavior in rats.
    Arolfo MP; McMillen BA
    Physiol Behav; 1999 Dec 1-15; 68(1-2):93-8. PubMed ID: 10627067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
    Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A
    Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1990 Aug; 52(2):206-11. PubMed ID: 2148812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.
    Svartengren J; Pettersson E; Björk A
    Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amperozide, a putative anti-psychotic drug: uptake inhibition and release of dopamine in vitro in the rat brain.
    Eriksson E
    Life Sci; 1990; 47(23):2111-7. PubMed ID: 1979998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.